Regulator-Requested Non-Interventional Postauthorization Safety and Effectiveness Studies for Oncology Drugs: A Systematic Review

Zhang, X; Chen, L; Bracco, OL; Setoguchi, S; Zhou, W; Burcu, M

Zhang, X (通讯作者),Merck & Co Inc, Kenilworth, NJ 07033 USA.

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022; 111 (1): 155

Abstract

There has been a growing number of oncology drug approvals. Non-interventional postauthorization safety/effectives studies (PASSs/PAESs) aim to provid......

Full Text Link